AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Polyneuropathy, Inflammatory Demyelinating, Chronic

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) NCT06858579Phase 3191 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Scottsdale Dianthus Therapeutics ยท Tests: Claseprubart, Claseprubart, Placebo Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes. NCT06615622n/a1 site๐Ÿ“ Asyut Assiut University ยท Tests: Placebo Universal Chimeric Antigen Receptor T-Cell ๏ผˆUCAR T-cell๏ผ‰ Therapy Targeting CD19/B Cell Maturation Antigen ๏ผˆCD19/BCMA๏ผ‰ in Patients With r/r Neurological Autoimmune Diseases NCT06939166EARLY Phase 11 site๐Ÿ“ Tianjin Tianjin Huanhu Hospital ยท Tests: UCAR T-cell Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study NCT07264426n/a23 sites๐Ÿ“ Wilmington๐Ÿ“ Berlin๐Ÿ“ Bochum argenx ยท Tests: Efgartigimod PH20 SC Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT07032662Phase 2142 sites๐Ÿ“ Tucson๐Ÿ“ Carlsbad๐Ÿ“ Mission Hills Immunovant Sciences GmbH ยท Tests: Imeroprubart, Placebo High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project NCT06881979NA7 sites๐Ÿ“ Genova๐Ÿ“ Milan๐Ÿ“ Modena Istituti Clinici Scientifici Maugeri SpA ยท Tests: High-tech rehabilitative treatment, Rehabilitation A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT06290141Phase 3134 sites๐Ÿ“ Homewood๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles Sanofi ยท Tests: riliprubart, Placebo, riliprubart, Placebo, IVIg Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients NCT04929236Phase 36 sites๐Ÿ“ Birmingham๐Ÿ“ Orange๐Ÿ“ Louisville Octapharma ยท Tests: Panzyga A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) NCT06798012Phase 220 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Jacksonville Takeda ยท Tests: TAK-411 Two Dose Levels of Privigen in Pediatric CIDP NCT03684018Phase 49 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Iowa City CSL Behring ยท Tests: IgPro10 Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT07154524n/a1 site๐Ÿ“ Ulm University of Ulm Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment NCT07304154Phase 110 sites๐Ÿ“ Newport Beach๐Ÿ“ Palo Alto๐Ÿ“ New York Kite, A Gilead Company ยท Tests: KITE-363, Fludarabine, Cyclophosphamide CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases NCT07337785EARLY Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning Hizentraยฎ in Inflammatory Neuropathies - pHeNIx Study NCT04672733n/a27 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Aubagne CSL Behring ยท Tests: Hizentra A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP NCT07091630Phase 389 sites๐Ÿ“ Birmingham๐Ÿ“ Rancho Mirage๐Ÿ“ Colorado Springs argenx ยท Tests: Empasiprubart IV, Placebo IV IVIG vs SCIG in CIDP NCT05584631Phase 11 site๐Ÿ“ New Brunswick Rutgers, The State University of New Jersey ยท Tests: Intravenous immune globulin G, Subcutaneous immune globulin G Biorepository and Registry for Plasma Exchange Patients NCT05004493n/a1 site๐Ÿ“ Iowa City Charles M Knudson Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices NCT07273903n/a2 sites๐Ÿ“ Dรผsseldorf๐Ÿ“ Mรผnster Heinrich-Heine University, Duesseldorf A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care NCT06538064n/a15 sites๐Ÿ“ Rancho Mirage๐Ÿ“ San Francisco๐Ÿ“ New Haven Takeda ยท Tests: No Intervention Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy NCT06714838Phase 31 site๐Ÿ“ Amsterdam Amsterdam University Medical Center (UMC), Location Academiโ€ฆ ยท Tests: Rituximab (Mabthera) Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP) NCT06968975n/a1 site๐Ÿ“ Swiftwater Sanofi Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT04881682Phase 21 site๐Ÿ“ Ulm University of Ulm ยท Tests: Immunoadsorption, Immunoglobulins A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy NCT07540221Phase 315 sites๐Ÿ“ Rancho Mirage๐Ÿ“ Coral Springs๐Ÿ“ Miami Grifols Therapeutics LLC ยท Tests: Gamunex-C, Xembify A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT06752356Phase 35 sites๐Ÿ“ Stamford๐Ÿ“ Miami๐Ÿ“ Tampa Kedrion S.p.A. ยท Tests: Immune globulin (human) 10% solution for intravenous administration Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System NCT04561557EARLY Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: CT103A cells, Cyclophosphamide and fludarabine Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) NCT04589299Phase 44 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus C๐Ÿ“ Copenhagen University of Aarhus ยท Tests: Immunoglobulin Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) NCT05327114Phase 2, Phase 3120 sites๐Ÿ“ Centennial๐Ÿ“ Coral Springs๐Ÿ“ Maitland Janssen Research & Development, LLC ยท Tests: Nipocalimab, Placebo Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases NCT07022197Phase 1, Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University General Hospital ยท Tests: BAFF-R CART Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease NCT07478172NA1 site๐Ÿ“ Columbia University of Missouri-Columbia ยท Tests: Whole-body Electrical Muscle Stimulation Exercise
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy